Key Highlights

  • Aethlon Medical secured a USPTO notice of allowance for a Patent related to managing viral infections and their symptoms.
  • The patent bolsters the intellectual property safeguarding the company's Hemopurifier system.
  • The announcement does not include advancements in clinical research, regulatory status, or new Capital initiatives.

Aethlon Medical, Inc. (NASDAQ: AEMD) secured a notice of allowance from the USPTO for a patent regarding technology for managing viral infections and their symptoms.

What Happened

The move bolsters the intellectual property safeguarding its Hemopurifier system; however, the announcement does not include advancements in clinical research, regulatory status, or new capital initiatives.

Market Reaction

The disclosed information does not include stock price or trading data for Aethlon Medical following the patent allowance.

Outlook

The disclosed information does not include specific forward guidance beyond the strengthened patent position surrounding the Hemopurifier system.